☆ 4.7 Article

Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion

JOURNAL OF MEDICAL VIROLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medicine, Research & Experimental

Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets

Masoumeh Farahani et al.

Summary: Understanding the molecular mechanisms of host response to SARS-CoV-2 infection is crucial for disease understanding and treatment planning. By identifying pathogenic mechanisms and developing vaccines and drugs, it can aid in combating COVID-19. Through discussions on signaling events and cell death signaling following virus infection, potential pathway-based therapeutic targets and drug candidates were introduced.

BIOMEDICINE & PHARMACOTHERAPY (2022)

添加到收藏夹

Review Oncology

Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns

Zi-Li Yu et al.

Summary: This review summarizes the latest research and advancements on small extracellular vesicle programmed death protein 1 ligand (sEV PD-L1). It highlights the high expression of PD-L1 on sEVs and its role in immunosuppression and immunotherapy resistance. sEV PD-L1 has potential as a predictive biomarker for clinical responses to immunotherapy. However, there are challenges and problems regarding the further understanding and application of sEV PD-L1.

NPJ PRECISION ONCOLOGY (2022)

添加到收藏夹

Review Immunology

Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms

Abdollah Jafarzadeh et al.

Summary: Lymphopenia, a major immunological abnormality in COVID-19 patients, is strongly associated with mortality rate. The reduction of lymphocytes may be caused by both SARS-CoV-2- and immune-mediated mechanisms, as well as metabolic and biochemical changes in patients. Preventing lymphopenia could potentially help improve patient outcomes.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

Rajendra Karki et al.

Summary: The combination of TNF-alpha and IFN-gamma induces inflammatory cell death characterized by PANoptosis, which can be inhibited to protect mice from the pathological effects and death caused by COVID-19. Blocking the cytokine-mediated inflammatory cell death signaling pathway may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.

CELL (2021)

添加到收藏夹

Review Immunology

T Cells: Warriors of SARS-CoV-2 Infection

Paola de Candia et al.

Summary: Severe infection with SARS-CoV-2 is characterized by massive cytokine release and T cell loss. The exaggerated host immune response, possibly dependent on T cell immunological memory, may significantly contribute to immunopathology and massive collateral damage in COVID-19 patients, especially in adults compared with children.

TRENDS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Microbiology

Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses

Hui Feng et al.

Summary: IRF1, a key nuclear factor, not only activates interferon genes, but also regulates host defense against invading pathogens. Conserved in vertebrates, IRF1 plays an important role in combating viral infections.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Piyada Supasa et al.

Summary: Research on the UK-dominant variant B.1.1.7 shows that it is harder to neutralize than the parental virus, but widespread escape from antibodies or monoclonal antibodies has not been observed yet.

CELL (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Epithelial response to IFN-γ promotes SARS-CoV-2 infection

Julian Heuberger et al.

Summary: The study suggests that elevated IFN-gamma in COVID-19 can promote differentiation of intestinal epithelial cells into mature enterocytes expressing high levels of ACE2, increasing susceptibility to SARS-CoV-2 infection.

EMBO MOLECULAR MEDICINE (2021)

添加到收藏夹

Letter Oncology

SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry

Rose K. C. Moritz et al.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Article Immunology

Interferon-inducer antivirals: Potential candidates to combat COVID-19

Ashkan Bagheri et al.

Summary: In response to the pandemic urgency of COVID-19, drug repurposing is being explored as a potential solution. Some existing antiviral drugs have shown promise in combating SARS-CoV-2 and warrant further investigation and evaluation.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

添加到收藏夹

Article Oncology

Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma

Tadashi Shiraishi et al.

ONCOLOGY (2021)

添加到收藏夹

Letter Immunology

Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19

Jiezhong Chen et al.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Oncology

SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

Mario Mandala et al.

Summary: In ambulatory cancer patients with asymptomatic or pauci-symptomatic SARS-CoV-2 infection, the safety of targeted therapies, chemotherapy, or immune checkpoint inhibitors therapy remains uncertain. A prospective study conducted in Bergamo, Italy found that SARS-CoV-2 positive patients had a significantly higher mortality rate and more frequent serious adverse events compared to SARS-CoV-2 negative patients.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Oncology

COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report

Angelo Dipasquale et al.

Summary: The distinction between COVID-19 and immune-related pneumonia can be challenging in oncology practice, with a risk of lung injury by SARS-CoV-2 increasing the risk of immune-related adverse events. Screening before starting immunotherapy and awareness of this phenomenon can help interpret treatment changes and facilitate timely diagnostic work-up.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation

Jessica Sook Yuin Ho et al.

Summary: The use of TOP1 inhibitors suppresses lethal inflammation caused by SARS-CoV-2, reducing disease severity and mortality, potentially serving as an effective host-directed therapy. TPT and its derivatives are affordable clinical-grade inhibitors, showing promise in combating severe COVID-19 infection.

CELL (2021)

添加到收藏夹

Article Medicine, General & Internal

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro

Hsiang-Chi Huang et al.

Summary: By targeting the glycosylation of viral spike protein, particularly through inhibiting STT3A, there is a potential to reduce infectivity of SARS-CoV-2 and its variants, enhancing the neutralizing abilities of antibodies, vaccines, or convalescent sera and reducing the spread of SARS-CoV-2 variants. An ADC coupling non-neutralization anti-spike antibody with NGI-1 shows promising efficacy in targeting SARS-CoV-2-infected cells.

EBIOMEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

Maria Antonietta Isgro et al.

Summary: This study investigated the proportion of COVID-19 infection among cancer patients and healthcare providers in Naples, Italy, finding a significantly lower positivity rate among patients receiving ICIs treatment, suggesting ICIs treatment may be a protective factor against COVID-19 infection.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut

Sergio Triana et al.

Summary: An exacerbated pro-inflammatory immune response contributes to COVID-19 pathology, with the gut identified as a prime target of SARS-CoV-2 infection. Infected cells activate strong pro-inflammatory programs and produce interferon, while expression of interferon-stimulated genes is limited to bystander cells.

MOLECULAR SYSTEMS BIOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective

Seyed Hootan Hamidi et al.

Summary: SARS-CoV-2 infection causes pulmonary or multi-organ damage, with factors like TGF-beta playing key roles. Pirfenidone, as an anti-fibrotic drug with antioxidant activity, may reduce lung injury during infection, making it a safe and effective option for treatment.

PHARMACOLOGICAL REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself

Marta Ferreira-Gomes et al.

Summary: The study found that in severe COVID-19 patients, plasmablasts shift from IFN to TGF-beta instruction to produce IgA antibodies that are not specific to dominant SARS-CoV-2 antigens.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Genetics & Heredity

Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic

Nitin Saksena et al.

Summary: In the past 20 years, three different coronaviruses have caused significant mortality in human populations, with SARS-CoV-2 leading to the ongoing COVID-19 pandemic. This review focuses on the host-pathogen interaction and the role of epigenetic machinery in regulating the disease, highlighting how SARS-CoV-2 manipulates host epigenetics to aid in infection and immunopathogenesis.

FRONTIERS IN GENETICS (2021)

添加到收藏夹

Article Virology

The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication

Benjamin E. Nilsson-Payant et al.

Summary: Research suggests that in SARS-CoV-2 infection, NF-kappa B activation plays a crucial role in viral replication in the absence of traditional IFN-I-related transcription factors. Silencing NF-kappa B transcription factors or using inhibitors can reduce virus replication. These findings contribute to a better understanding of SARS-CoV-2 replication mechanisms and provide a basis for the development of novel treatment approaches.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Microbiology

Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19

Cheng-Pu Sun et al.

Summary: This study introduces a versatile approach that enables rapid generation of mouse models for emerging infectious diseases within a month, aiding in the study of disease mechanisms and drug development. The created mouse model for COVID-19 accurately mimicked severe cases in patients and was successfully used in drug development.

PLOS PATHOGENS (2021)

添加到收藏夹

Review Oncology

The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes

Tasnim H. Beacon et al.

Summary: The broad epigenetic domain, marked by H3K4me3, is associated with cell identity, essential cell functions, and the metastatic potential of cancer cells. It interacts with various histone modifications and forms a hub of interactions involving transcription factors, enhancers, and super-enhancers. This dynamic chromatin structure supports frequent transcription bursts and may act as a transcription factory.

CLINICAL EPIGENETICS (2021)

添加到收藏夹

Review Oncology

Neutrophils in the era of immune checkpoint blockade

Julien Faget et al.

Summary: Neutrophils in tumors have been highlighted as playing a pivotal role in modulating the tumor microenvironment and antitumor immune response. Research targeting neutrophils could offer new treatment opportunities in the development of immune checkpoint blockade-based immunotherapies. Expanding the study of neutrophil impact on the response to immune checkpoint inhibitors may lead to new translational research avenues for better understanding neutrophil biology and improving patient treatment.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Review Immunology

The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients

Apurva Hariharan et al.

Summary: COVID-19 causes a cytokine storm mainly affecting the lungs, with elderly and patients with metabolic syndrome being more susceptible. Immunomodulation targeting NF-kappa B activation and inhibitors can potentially reduce the cytokine storm, alleviating the severity of COVID-19. Inhibition of the NF-kappa B pathway may play a therapeutic role in alleviating severe forms of COVID-19.

INFLAMMOPHARMACOLOGY (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Immunopathogenesis and treatment of cytokine storm in COVID-19

Jae Seok Kim et al.

Summary: Severe COVID-19 is characterized by systemic hyper-inflammation and cytokine storm, often leading to acute respiratory distress syndrome and multiple organ failure. Treatment of COVID-19 cytokine storm is crucial, with anti-inflammatory therapies playing a significant role. Various approaches are being used, including new cytokine-targeted therapies, to address the cytokine storm associated with COVID-19.

THERANOSTICS (2021)

添加到收藏夹

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Architecture of SARS-CoV-2 Transcriptome

Dongwan Kim et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Article Microbiology

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Zhuo Zhou et al.

CELL HOST & MICROBE (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2

Mahmoud Gheblawi et al.

CIRCULATION RESEARCH (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

IL-6: Relevance for immunopathology of SARS-CoV-2

E. O. Gubernatorova et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

Ka Shing Cheung et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Editorial Material Immunology

Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

Melissa Bersanelli

IMMUNOTHERAPY (2020)

添加到收藏夹

Editorial Material Oncology

Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?

Vincenzo Di Noia et al.

LUNG CANCER (2020)

添加到收藏夹

Letter Critical Care Medicine

COVID-19 cytokine storm: the interplay between inflammation and coagulation

Ricardo J. Jose et al.

LANCET RESPIRATORY MEDICINE (2020)

添加到收藏夹

Article Immunology

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Bo Diao et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Jin Liu et al.

EBIOMEDICINE (2020)

添加到收藏夹

Editorial Material Oncology

COVID-19 and cancer: what we know so far

Peter Sidaway

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Immunology

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Amr H. Sawalha et al.

CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19

Bakiye Goker Bagca et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Victor J. Costela-Ruiz et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

添加到收藏夹

Editorial Material Urology & Nephrology

Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic

Silke Gillessen et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Article Immunology

Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper

Sonu Bhaskar et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma

Wenjie Zhang et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Article Immunology

Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling

Benjamin Israelow et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

添加到收藏夹

Article Immunology

ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19

Bruna G. G. Pinto et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Letter Oncology

Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic

Hsu-Liang Chang et al.

LUNG CANCER (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Expanded encyclopaedias of DNA elements in the human and mouse genomes

Jill E. Moore et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Determinants of COVID-19 disease severity in patients with cancer

Elizabeth V. Robilotti et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Genetics & Heredity

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

Andrew D. Davidson et al.

GENOME MEDICINE (2020)

添加到收藏夹

Article Immunology

COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy

Cesar Martins da Costa et al.

IMMUNOTHERAPY (2020)

添加到收藏夹

Article Immunology

Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome

Lila Bouadma et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

A Granulocytic Signature Identifies COVID-19 and Its Severity

Joana Vitte et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Ludovico Cantuti-Castelvetri et al.

SCIENCE (2020)

添加到收藏夹

Review Oncology

The epigenetic implication in coronavirus infection and therapy

Sandra Atlante et al.

CLINICAL EPIGENETICS (2020)

添加到收藏夹

Article Microbiology

Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection

Jiya Sun et al.

FRONTIERS IN MICROBIOLOGY (2020)

添加到收藏夹

Review Immunology

Regulation of PD-L1 Expression by NF-κB in Cancer

Fabrizio Antonangeli et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients

Ralf Kircheis et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Review Cell Biology

PD-L1 degradation pathway and immunotherapy for cancer

Qian Gou et al.

CELL DEATH & DISEASE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Ke Wang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19?

Hubert Hondermarck et al.

FASEB BIOADVANCES (2020)

添加到收藏夹

Review Immunology

TIM3 comes of age as an inhibitory receptor

Yochai Wolf et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Review Immunology

Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors

Juwhan Choi et al.

IMMUNE NETWORK (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Comparative transcriptomics method to infer gene coexpression networks and its applications to maize and rice leaf transcriptomes

Yao-Ming Chang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

添加到收藏夹

Article Oncology

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

Chia-Wei Li et al.

CANCER CELL (2018)

添加到收藏夹

Review Microbiology

ISG15 in antiviral immunity and beyond

Yi-Chieh Perng et al.

NATURE REVIEWS MICROBIOLOGY (2018)

添加到收藏夹

Review Medicine, General & Internal

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Michael A. Postow et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Oncology

Soluble immune checkpoints in cancer: production, function and biological significance

Daqian Gu et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

添加到收藏夹

Article Cell Biology

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Angel Garcia-Diaz et al.

CELL REPORTS (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

AAV vector distribution in the mouse respiratory tract following four different methods of administration

Lisa A. Santry et al.

BMC BIOTECHNOLOGY (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

Writing, erasing and reading histone lysine methylations

Kwangbeom Hyun et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2017)

添加到收藏夹

Article Oncology

Deubiquitination and Stabilization of PD-L1 by CSN5

Seung-Oe Lim et al.

CANCER CELL (2016)

添加到收藏夹

Review Medicine, Research & Experimental

Immunity, inflammation, and cancer: an eternal fight between good and evil

Shabnam Shalapour et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

添加到收藏夹

Article Immunology

Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells

Shasha Song et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2014)

添加到收藏夹

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

添加到收藏夹

Review Oncology

PD-1 as a potential target in cancer therapy

David F. McDermott et al.

CANCER MEDICINE (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Differential expression in RNA-seq: A matter of depth

Sonia Tarazona et al.

GENOME RESEARCH (2011)

添加到收藏夹

Article Medicine, General & Internal

Serious Adverse Events During Ruxolitinib Treatment Discontinuation in Patients With Myelofibrosis

Ayalew Tefferi et al.

MAYO CLINIC PROCEEDINGS (2011)

添加到收藏夹

Review Oncology

Epigenetics in cancer

Shikhar Sharma et al.

CARCINOGENESIS (2010)

添加到收藏夹

Article Multidisciplinary Sciences

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie et al.

NATURE (2009)

添加到收藏夹

Review Genetics & Heredity

ChIP-seq: advantages and challenges of a maturing technology

Peter J. Park

NATURE REVIEWS GENETICS (2009)

添加到收藏夹

Article Toxicology

Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3′-diindolylmethane in Sprague-Dawley rats

DA Leibelt et al.

TOXICOLOGICAL SCIENCES (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.